“Eric is recognized as an international expert in toxicologic pathology, with specific expertise in reproductive pathology. He has served as an expert consultant for several panels that we have organized to help resolve issues involving reproductive endpoints in drug development programs. Eric’s extensive knowledge and vast experience were critical in resolving the issues in question and enabling our sponsors to continue their drug development programs.”

During the more than 30 years in which Eric van Esch has worked as a toxicologic pathologist, he has worked together with many others, on studies, on publications, and served on many different boards. Few testimonials of his colleagues are available below. I have known Eric for last 25 years or so as a friend and colleague. I had an input in his early training as a toxicologic pathologist in his formative period at Organon, Netherlands. I had supervised his training program at Huntingdon Life Sciences for a period. I have followed his career with interest and was very pleased to see him coming up as an expert especially in the area of reproductive pathology. He has a creditable list of publications which is impressive. I had several occasions to work with Eric on important issues in toxicologic Pathology and found him valuable at all occasions. He is well liked and respected in Europe as a toxicologic pathologist. I hope to work with Eric on future occasions and I wish him the very best in his new venture as an independent consultant in this field.

Eric and I have worked together over 2 years on the STP INHAND Committee for the Female Reproductive Tract and just recently as founding members of the newly created STP Reproductive Pathology Special Interest Group (SIG). Eric’s expertise and extensive knowledge in Reproductive Toxicologic Pathology have helped tremendously in the writing of the INHAND document. He is a wonderful “team player” and has worked well with all members of both the INHAND committee and the Reproductive Pathology SIG. His ideas and approaches to toxicologic pathology are innovative and progressive. I wish Eric all the best with his new venture and I know he will continue to make excellent contributions to the field of pathology as an independent consultant.

I met Eric for the first time under what could be described as uncomfortable circumstances when the company I worked for at the time (Schering-Plough) purchased the company that Eric worked for at the time (Organon). This initial meeting could have been strained as a result of the uncertainty of the situation. I recall that Eric was approachable and open to hearing what this new company might bring. He was welcoming rather than simply resisting anything we might propose. He more rather accepted us as new colleagues. Naturally and appropriately, he also wanted to partner in shaping our combined future together. This was my first encounter with Eric. With some time and exposure to his work and written reports, I came to know Eric more as a professional colleague rather than quite simply another scientist/pathologist. Eric performs a careful review of the in-life, clinicopathologic and histopathologic findings for a study in order to produce an accurate and comprehensive evaluation of the incidental and test substance findings so that genuine toxicity findings are illustrated in a clear manner. It has been my experience that Eric, moreover takes the data one-step further and considers the mechanistic implications as well as the human risk relevance of the combined data. Eric is prepared to defend a scientific position however is also comfortable stating, “I don’t know”. He conveys findings in a clear, readable manner. From a personal perspective, Eric has patiently explained pathology findings, or comparative female reproductive physiology, to me in a manner that is patient and understandable. Note for example the “Monograph on the Reproductive System of the female Macaque”, in the 2008 Supplement of Toxicologic Pathology. It has been a pleasure to get to know Eric on both a professional and personal level. I wish him the best.

Pathological evaluation today is characterized by keywords like Specialization, Innovation, Integration, and Regulation. From there, interpretation of toxicologic studies among others requires profound knowledge, experience, and overview – in short: insight. With the new consultancy named “Insight Pathology” Eric van Esch willingly challenges these virtues. Knowing Eric for a long time, I can attest to him being the personification of: Experience – with fundamental background knowledge on anatomical and clinical pathology, techniques, and reporting programs. For me it has always been a great benefit consulting him on sophisticated organ systems, on hidden and on essential details. Overview – his professional judgement on feasibility, on guidelines, and on essentials of industrial partners, where his own roots emerge from. Insight – what actually summarizes his professional skills, on what’s behind a finding, the how and why, and the future expectation on a compound. I am not surprised that Eric chose “Insight Pathology” for the name of his consultancy, since knowing him to personify “Insight Pathology” as his own personal professional program. Eric will undoubtedly be a key figure in driving toxicologic research ahead. I wish Eric a great start in his new business and the best future success as a consultant.

Enter your answer here